Reactivation-based molecular interaction sensors

• US 7,335,478 B2
• Filed: 07/29/2002
• Issued: 02/26/2008
• Est. Priority Date: 04/18/2002
• Status: Expired due to Fees

• Current Assignee: Kalobios Incorporated
• Original Assignee: KaloBios Pharmaceuticals, Inc.
• Inventors: Her, Jeng-Horng, Balint, Robert F.
• Primary Examiner(s): Le; Long V.
• Assistant Examiner(s): CHEU, CHANGHWA J
• Application Number:
  US10/208,730
• Publication Number:
  US 20030198971A1
• Time in Patent Office: 2,038 Days
• Field of Search: 435/7.1, 435/7.92, 435/6, 435/333, 436/86, 436/164
• US Class Current: 435/7.1
• CPC Class Codes: G01N 33/542 with steric inhibition or signal modification, e.g. fluorescent quenching

Abstract

This invention provides methods and systems for linking the functional activation of a responder molecule to the interaction of two or more binding ensemble members of interest either in vitro or in vivo, and thereby producing a signal, phenotype, or other functional output in response to the interaction of the binding ensemble members. The systems comprise a responder, an inhibitor of the responder, and an inhibitor of the inhibitor, or “reactivator” of the responder, and interacting components. Two binding ensemble members are complexed to the other components of the system in such a way that interaction of the binding ensemble members, either directly or via additional ensemble members, causes a shift in the equilibrium of inhibitor binding from the responder to the reactivator, thereby functionally activating the responder.

Claims

1. A method for detecting an interaction of binding ensemble members, comprising the steps of:

providing a responder complex comprising linked components;

a responder molecule, an inhibitor of the responder molecule, and a first member of a binding ensemble;

providing a reactivator complex comprising a reactivator molecule linked to a second member of the binding ensemble;

combining the responder complex and the reactivator complex, where upon the interaction of the first and the second binding ensemble member, the reactivator competitively or allosterically displaces the inhibitor from the responder molecule; and

detecting an activity of the responder molecule, thereby detecting the interaction of the first and the second binding ensemble members.

2. The method of claim 1, wherein the first member of the binding ensemble is linked to the responder molecule and the inhibitor is linked to the responder molecule.

3. The method of claim 2, wherein the first member of the binding ensemble and the responder molecule are linked by a first covalent linkage;

the inhibitor and the responder molecule are linked by a second covalent linkage; and

further, wherein the reactivator and the second member of the binding ensemble by a third covalent linkage.

4. The method of claim 2, wherein the first member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

5. The method of claim 2, wherein the second member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

6. The method of claim 2, further comprising a third member of the binding ensemble, wherein the first member of the binding ensemble and the second member of the binding ensemble interact with the third member of the binding ensemble.

7. The method of claim 6, wherein the third member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

8. The method of claim 6, wherein the first member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

9. The method of claim 6, wherein the second member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

10. The method of claim 6, wherein the third member of the binding ensemble is a member of a plurality of candidate binding ensemble members;

the first member of the binding ensemble is a member of a plurality of candidate binding ensemble members; and

the second member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

11. The method of claim 1, wherein the responder molecule is linked to the first member of the binding ensemble, and the inhibitor is linked to the first member of the binding ensemble.

12. The method of claim 11, wherein the first member of the binding ensemble and the responder molecule are linked by a first covalent linkage, the inhibitor and the first member of the binding ensemble are linked by a second covalent linkage;

and further, wherein the reactivator and the second member of the binding ensemble are linked by a third covalent linkage.

13. The method of claim 12, wherein the first member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

14. The method of claim 12, wherein the second member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

15. The method of claim 12, further comprising a third member of the binding ensemble, wherein the first member of the binding ensemble and the second member of the binding ensemble interact with the third member of the binding ensemble.

16. The method of claim 15, wherein the third member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

17. The method of claim 15, wherein the first member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

18. The method of claim 15, wherein the second member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

19. The method of claim 15, wherein the third member of the binding ensemble is a member of a plurality of candidate binding ensemble members;

and further, wherein the first member of the binding ensemble is a member of a plurality of candidate binding ensemble members and the second member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

20. The method of claim 1, wherein the responder molecule is linked to the inhibitor, and the first member of the binding ensemble is linked to the inhibitor.

21. The method of claim 20, wherein the responder molecule and the inhibitor are linked by a first covalent linkage, the first member of the binding ensemble and the inhibitor are linked by a second covalent linkage, and further, wherein the reactivator and the second member of the binding ensemble are linked by a third covalent linkage.

22. The method of claim 20, wherein the responder molecule and the inhibitor are linked by a non-covalent linkage, the first member of the binding ensemble and the inhibitor are linked by a covalent linkage, and further, wherein the reactivator and the second member of the binding ensemble are linked by a covalent linkage.

23. The method of claim 21, wherein the first member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

24. The method of claim 21, wherein the second member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

25. The method of claim 21, further comprising a third member of the binding ensemble, wherein the first member of the binding ensemble and the second member of the binding ensemble interact with the third member of the binding ensemble.

26. The method of claim 25, wherein the third member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

27. The method of claim 25, wherein the first member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

28. The method of claim 25, wherein the second member of the binding ensemble is a member of a plurality of candidate binding ensemble members.

29. The method of claim 25, wherein the third member of the binding ensemble is a member of a plurality of candidate binding ensemble members;

and further, wherein the first member of the binding ensemble is a member of a plurality of candidate binding ensemble members and the second member of the binding ensemble is a member of a plurality of candidate binding ensemble members.